Gene therapy for prostate cancer

Gene therapy for prostate cancer

Mitchell S Steiner and Jeffrey R Gingrich Department of Urology, University of Tennessee, Memphis, Tennessee 38163 _________________________________________________________________________________________________ Correspondence: Mitchell S. Steiner, MD, Department of Urology, University of Tennessee Medical Center, 956 Court Avenue, Memphis, Tennessee 38163. Telephone: 901-448-1492; Fax: 901-44...

Progress in Gene Therapy for Prostate Cancer

Gene therapy has held promise to correct various disease processes. Prostate cancer represents the second leading cause of cancer death in American men. A number of clinical trials involving gene therapy for the treatment of prostate cancer have been reported. The ability to efficiently transduce tumors with effective levels of therapeutic genes has been identified as a fundamental barrier to e...

Gene therapy strategies in prostate cancer.

Androgen ablation is the choice of treatment for patients with advanced prostate cancer. Although untreated tumors are mostly androgen-dependent, hormone withdrawal is only palliative. The major problem in prostate cancer treatment represents the progression to androgen-independent growth during therapy, rendering current strategies inefficient. Thus, there is an urgent need to develop novel tr...

Gene Therapy in Advanced Prostate Cancer:

Development of a Nanotechnology Platform for Prostate Cancer Gene Therapy

X Approved for public release; distribution unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. Public reporting burden for this collection of information is estimated to average 1 hour per response, including t...